Fixing frataxin: ‘ironing out’ the metabolic defect in Friedreich's ataxia
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The metabolically active and redox‐active mitochondrion appears to play a major role in the cellular metabolism of the transition metal, iron. Frataxin, a mitochondrial matrix protein, has been identified as playing a key role in the iron metabolism of this organelle due to its iron‐binding properties and is known to be essential for iron–sulphur cluster formation. However, the precise function of frataxin remains elusive. The decrease in frataxin expression, as seen in the inherited disorder F riedreich's ataxia, markedly alters cellular and mitochondrial iron metabolism in both the mitochondrion and the cell. The resulting dysregulation of iron trafficking damages affects tissues leading to neuro‐ and cardiodegeneration. This disease underscores the importance of iron homeostasis in the redox‐active environment of the mitochondrion and the molecular players involved. Unravelling the mechanisms of altered iron metabolism in F riedreich's ataxia will help elucidate a biochemical function for frataxin. Consequently, this will enable the development of more effective and rationally designed treatments. This review will focus on the emerging function of frataxin in relation to the observed alterations in mitochondrial iron metabolism in F riedreich's ataxia. Tissue‐specific alterations due to frataxin loss will also be discussed, as well as current and emerging therapeutic strategies. Linked Articles: This article is part of a themed issue on Mitochondrial Pharmacology: Energy, Injury & Beyond. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2014.171.issue‐8
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Function and biogenesis of iron-sulphur proteins
Lill, R. (2009) · Nature · doi:10.1038/nature08301 · Cited by 1,167
Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
Fleming, M. D., Trenor, C. C., Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., & Andrews, N. C. (1997) · Nature Genetics · doi:10.1038/ng0897-383 · Cited by 1,159 · cited 1×
“The resulting iron(II) can then be exported to the cytosol via ferrous-selective iron transporters such as the divalent metal transporter-1 (DMT1; Fleming et al., 1997; Andrews, 1999).”
BackgroundThe role of iron regulatory proteins in mammalian iron homeostasis and disease
Rouault, T. A. (2006) · Nature Chemical Biology · doi:10.1038/nchembio807 · Cited by 1,055 · cited 3×
“The specific IRE-binding activity of IRP1 and the rate of degradation of IRP2 are decreased by the level of iron in the cell (Rouault, 2006).”
BackgroundKakhlon, O., & Cabantchik, Z. I. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01006-7 · Cited by 839 · cited 1×
“In non-erythroid cells newly assimilated cytosolic iron, released from the endosome, enters a poorly characterized compartment known as the ‘labile iron pool’ (LIP; Jacobs, 1977; Kakhlon and Cabantchik, 2002; Shvartsman and Ioav Cabantchik, 2012; Lawen and Lane, 2013).”
BackgroundOhgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775
The Steap proteins are metalloreductases
Ohgami, R. S., Campagna, D. R., McDonald, A., & Fleming, M. D. (2006) · Blood · doi:10.1182/blood-2006-02-003681 · Cited by 744 · cited 1×
“Once released from Tf, iron(III) is reduced to iron(II), either by a ferrireductase, such as the six transmembrane epithelial antigen of the prostate 3 (Ohgami et al., 2005; 2006), or possibly by small MW reductants such as ascorbate (Nunez et al., 1990; Lane et al., 2013a).”
BackgroundPuccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738 · cited 3×
“Over the years, subsequent studies of frataxin deficiency in various mouse and cell models have generally recapitulated what has been observed in yeast (Rotig et al., 1997; Puccio et al., 2001).”
BackgroundMethodIron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation
Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709 · cited 1×
“This leads to increased ferritin translation and decreased TfR1 translation (Casey et al., 1988; Henderson and Kuhn, 1995; Popovic and Templeton, 2004).”
BackgroundMuckenthaler, M. U., Galy, B., & Hentze, M. W. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155521 · Cited by 701
Mitoferrin is essential for erythroid iron assimilation
Shaw, G. C., Cope, J. J., Li, L., Corson, K., Hersey, C., Ackermann, G. E., Gwynn, B., Lambert, A. J., Wingert, R. A., Traver, D., et al. (2006) · Nature · doi:10.1038/nature04512 · Cited by 624
A cytosolic iron chaperone that delivers iron to ferritin
Shi, H., Bencze, K. Z., Stemmler, T. L., & Philpott, C. C. (2008) · Science · doi:10.1126/science.1157643 · Cited by 536 · cited 3×
“…iron loading into cytosolic ferritin and the iron-dependent prolyl hydroxylases, as well as an asparaginyl hydroxylase, that are responsible for hydroxylating the hypoxia-inducible factor (HIF)1α prior to its proteasomal degradation (Shi et al., 2008; Nandal et al., 2011; Leidgens et al., 2013).”
BackgroundMammalian iron metabolism and its control by iron regulatory proteins
Anderson, C. P., Shen, M., Eisenstein, R. S., & Leibold, E. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.010 · Cited by 493
Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics
Koeppen, A. H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.01.010 · Cited by 447
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia
Herman, D., Jenssen, K., Burnett, R., Soragni, E., Perlman, S. L., & Gottesfeld, J. M. (2006) · Nature Chemical Biology · doi:10.1038/nchembio815 · Cited by 442 · cited 3×
“Epigenetic therapy The transcriptional silencing of the Fxn gene by GAA repeat expansion is accompanied by histone hypoacetylation, consistent with a heterochromatin-mediated repression mechanism (Herman et al., 2006).”
BackgroundInfluentialSelective iron chelation in Friedreich ataxia: biologic and clinical implications
Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409
A human mitochondrial ferritin encoded by an intronless gene
Levi, S., Corsi, B., Bosisio, M., Invernizzi, R., Volz, A., Sanford, D., Arosio, P., & Drysdale, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100141200 · Cited by 400
Eaton, J. W., & Qian, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00772-4 · Cited by 389 · cited 2×
“…toxic reactive oxygen species (ROS) that can readily oxidize BJP British Journal ofPharmacology DOI:10.1111/bph.12470 www.brjpharmacol.org 2174 British Journal of Pharmacology (2014) 171 2174–2190 © 2013 The British Pharmacological Society proteins, lipids and nucleic acids (Eaton and Qian, 2002).”
BackgroundInfluentialWong, A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.425 · Cited by 374 · cited 2×
“In vitro examination of the therapeutic potential of iron chelators has shown that these compounds rescue cells from iron toxicity (Wong et al., 1999) and restore aconitase activity as well as mitochondrial membrane and redox potentials (Kakhlon et al., 2008).”
BackgroundDeficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis.
The Tübingen 2000 Screen Consortium, Wingert, R. A., Galloway, J. L., Barut, B., Foott, H., Fraenkel, P., Axe, J. L., Weber, G. J., Dooley, K., Davidson, A. J., et al. (2005) · Nature · doi:10.1038/nature03887 · Cited by 370 · cited 2×
“Like FRDA, sideroblastic anaemia is characterized by iron loading in the mitochondria (Wingert et al., 2005).”
BackgroundUrrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N. P., Arredondo, M., González‐Billault, C., & Núñez, M. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12244 · Cited by 364
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Manganese Superoxide Dismutase: Guardian of the Powerhouse
Holley, A. K., Bakthavatchalu, V., Velez-Roman, J. M., & St. Clair, D. K. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12107114 · Cited by 358 · cited 1×
“The mitochondrion is a vital cellular organelle due to its central roles in energy transduction, apoptosis and the synthesis of crucial metabolites (Holley et al., 2011; Kubli and Gustafsson, 2012).”
BackgroundDistinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells
Asano, T., Komatsu, M., Yamaguchi-Iwai, Y., Ishikawa, F., Mizushima, N., & Iwai, K. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01437-10 · Cited by 265 · cited 2×
“release of iron from the iron storage protein, ferritin (Ollinger and Roberg, 1997; Asano et al., 2011).”
BackgroundIron-Dependent Self-Assembly of Recombinant Yeast Frataxin: Implications for Friedreich Ataxia
Adamec, J., Rusnak, F., Owen, W. G., Naylor, S., Benson, L. M., Gacy, A. M., & Isaya, G. (2000) · The American Journal of Human Genetics · doi:10.1086/303056 · Cited by 255
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
Lin, L., Goldberg, Y. P., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2005-05-1845 · Cited by 241 · cited 2×
“Furthermore, HJV that is shed by skeletal muscle is believed to be soluble HJV, a negative regulator of hepcidin (Lin et al., 2005), while the liver mainly expresses membrane-bound or GPI-linked HJV, which enhances hepcidin expression (Babitt et al., 2007).”
BackgroundApoptotic versus autophagic cell death in heart failure
Knaapen, M. W. M., Davies, M. J., De Bie, M., Haven, A. J., Martinet, W., & Kockx, M. M. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00290-5 · Cited by 233
Crystal Structure of Human Frataxin
Dhe-Paganon, S., Shigeta, R., Chi, Y.-I., Ristow, M., & Shoelson, S. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000407200 · Cited by 226
Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1)
Lesuisse, E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg096 · Cited by 226
Friedreich ataxia: the oxidative stress paradox
Seznec, H., Simon, D., Bouton, C., Reutenauer, L., Hertzog, A., Golik, P., Procaccio, V., Patel, M., Drapier, J.-C., Koenig, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi042 · Cited by 219 · cited 2×
“, 2010), there is significant debate over whether frataxin deficiency leads to an increase in cellular ROS (Seznec et al., 2005).”
BackgroundActivation of the HIF Prolyl Hydroxylase by the Iron Chaperones PCBP1 and PCBP2
Nandal, A., Ruiz, J. C., Subramanian, P., Ghimire-Rijal, S., Sinnamon, R. A., Stemmler, T. L., Bruick, R. K., & Philpott, C. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.015 · Cited by 204
Distinct iron-sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells
Tong, W., & Rouault, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5692 · Cited by 194 · cited 5×
“In humans, de novo ISC synthesis is facilitated by the cysteine desulphurase, NFS1, that provides sulphur (Land and Rouault, 1998; Tong et al., 2003), and the assembly of the cluster occurs on the scaffold protein, ISCU (Tong and Rouault, 2000; Frazzon and Dean, 2003).”
BackgroundInfluentialTong, W.-H., Jameson, G. N. L., Huynh, B. H., & Rouault, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732541100 · Cited by 194 · cited 1×
“In humans, de novo ISC synthesis is facilitated by the cysteine desulphurase, NFS1, that provides sulphur (Land and Rouault, 1998; Tong et al., 2003), and the assembly of the cluster occurs on the scaffold protein, ISCU (Tong and Rouault, 2000; Frazzon and Dean, 2003).”
BackgroundGakh, O., Park, S., Liu, G., Macomber, L., Imlay, J. A., Ferreira, G. C., & Isaya, G. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi461 · Cited by 184 · cited 2×
“The ferroxidase-devoid Yhf1 protein could not mineralize and detoxify iron, producing hypersensitive to oxidative stress, yet chaperone function remained intact (Gakh et al., 2006).”
BackgroundMitochondrial Ferritin: A New Player in Iron Metabolism
Drysdale, J., Arosio, P., Invernizzi, R., Cazzola, M., Volz, A., Corsi, B., Biasiotto, G., & Levi, S. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0577 · Cited by 180 · cited 2×
“This proposed role becomes even less likely considering that (i) human frataxin does not selfassemble, even under iron-loaded conditions (Cavadini et al., 2002) and (ii) the mitochondrial iron storage protein, Ftmt, was discovered in human tissues (Drysdale et al., 2002).”
BackgroundFoury, F., & Roganti, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111789200 · Cited by 171 · cited 4×
“First identified in Saccharomyces cerevisiae (MRS3/MRS4; Foury and Roganti, 2002), the Mfrns are currently the only known transport proteins in eukaryotes to import iron across the inner membrane (Shaw et al., 2006).”
BackgroundInfluentialRedistribution of accumulated cell iron: a modality of chelation with therapeutic implications
Sohn, Y.-S., Breuer, W., Munnich, A., & Cabantchik, Z. I. (2008) · Blood · doi:10.1182/blood-2007-07-102335 · Cited by 167 · cited 2×
“Deferiprone (DFP) is another small MW ligand that is able to cross both cellular and subcellular membranes (Kakhlon et al., 2010) and is being tested in clinical trials (Boddaert et al., 2007; Sohn et al., 2008).”
BackgroundTowards a structural understanding of Friedreich’s ataxia: the solution structure of frataxin
Musco, G., Stier, G., Kolmerer, B., Adinolfi, S., Martin, S., Frenkiel, T., Gibson, T., & Pastore, A. (2000) · Structure · doi:10.1016/s0969-2126(00)00158-1 · Cited by 166 · cited 1×
“The basic structure of frataxin consists of N- and C-terminal α-helices, flanked by a 5–7 strand antiparallel β-sheet in a ‘sandwich’ motif (Musco et al., 2000).”
BackgroundChen, O. S., Hemenway, S., & Kaplan, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192449599 · Cited by 152 · cited 1×
“Contrary to this notion, ISC formation is decreased when frataxin expression is deficient (Chen et al., 2002; Huang et al., 2009).”
BackgroundWang, J., Song, N., Jiang, H., Wang, J., & Xie, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.021 · Cited by 150 · cited 1×
“This represents one possible mechanism leading to neural degeneration (Urrutia et al., 2013; Wang et al., 2013).”
BackgroundColin, F., Martelli, A., Clémancey, M., Latour, J.-M., Gambarelli, S., Zeppieri, L., Birck, C., Page, A., Puccio, H., & Ollagnier de Choudens, S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja308736e · Cited by 148
Iron regulatory proteins secure mitochondrial iron sufficiency and function
Galy, B., Ferring-Appel, D., Sauer, S. W., Kaden, S., Lyoumi, S., Puy, H., Kölker, S., Gröne, H.-J., & Hentze, M. W. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.007 · Cited by 147 · cited 1×
“Mitochondrial ISC assembly and export systems serve as key regulators of iron homeostasis in eukaryotes, their status has a critical influence on the cellular uptake of iron and its intracellular distribution and utilization (Schalinske et al., 1997; Galy et al., 2010).”
BackgroundIron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia
Michael, S., Petrocine, S. V., Qian, J., Lamarche, J. B., Knutson, M. D., Garrick, M. D., & Koeppen, A. H. (2006) · The Cerebellum · doi:10.1080/14734220600913246 · Cited by 122 · cited 1×
“Interestingly, examination of heart samples from FRDA patients exhibited evidence of myocarditis with leukocyte infiltrations (Hejtmancik et al., 1949; Michael et al., 2006) and also presents a case for the role of inflammation in the progression of cardiomyopathy in FRDA.”
BackgroundCampanella, A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh232 · Cited by 109 · cited 1×
“Moreover, Ftmt has demonstrated a protective role against cellular defects caused by frataxin deficiency in FRDA models in yeasts and human cells, as well as in fibroblasts of FRDA patients (Campanella et al., 2004; 2009; Zanella et al., 2008).”
BackgroundDoes oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question
Armstrong, J. S., Khdour, O., & Hecht, S. M. (2010) · The FASEB Journal · doi:10.1096/fj.09-143222 · Cited by 107 · cited 7×
“Despite mounting evidence detailing the role of frataxin in the detoxification of ROS (Armstrong et al., 2010), there is significant debate over whether frataxin deficiency leads to an increase in cellular ROS (Seznec et al.”
BackgroundInfluentialMitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease
Huang, M. L.-H., Lane, D. J. R., & Richardson, D. R. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3921 · Cited by 103 · cited 3×
“, 1995), it is possible that any disruption in ISC synthesis could also adversely affect the rate of haem synthesis (Richardson et al., 2010; Huang et al., 2011).”
BackgroundSelf-citationFriedreich's Ataxia, No Changes in Mitochondrial Labile Iron in Human Lymphoblasts and Fibroblasts
Sturm, B., Bistrich, U., Schranzhofer, M., Sarsero, J. P., Rauen, U., Scheiber-Mojdehkar, B., de Groot, H., Ioannou, P., & Petrat, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408717200 · Cited by 73
Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment
Goncalves, S., Paupe, V., Dassa, E. P., & Rustin, P. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-20 · Cited by 66
Öllinger, K., & Roberg, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23707 · Cited by 65 · cited 2×
“release of iron from the iron storage protein, ferritin (Ollinger and Roberg, 1997; Asano et al., 2011).”
Background
Cited by
Murphy, E., Ardehali, H., Balaban, R. S., DiLisa, F., Dorn, G. W., Kitsis, R. N., Otsu, K., Ping, P., Rizzuto, R., Sack, M. N., et al. (2016) · Circulation Research · doi:10.1161/res.0000000000000104 · Cited by 458
Lane, D. J. R., Merlot, A. M., Huang, M. L.-H., Bae, D.-H., Jansson, P. J., Sahni, S., Kalinowski, D. S., & Richardson, D. R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.021 · Cited by 399
On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability
Khristich, A. N., & Mirkin, S. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007678 · Cited by 289
Iron alters cell survival in a mitochondria-dependent pathway in ovarian cancer cells
Bauckman, K., Haller, E., Taran, N., Rockfield, S., Ruiz-Rivera, A., & Nanjundan, M. (2015) · Biochemical Journal · doi:10.1042/bj20140878 · Cited by 41
Metadata
- Authors
- Anzovino, A., Lane, D. J. R., Huang, M. L., & Richardson, D. R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2014-03-28
- Volume
- 171
- Issue
- 8
- Pages
- 2174-2190
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1799590081
- Cited by
- 56
- References
- 52
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.